Product ID |
CAS Number |
Product Name |
Quantity |
AS-0967 |
75680-92-1 |
6-Chloro-pyridazine-3-carboxylic acid ethyl ester |
|
AS-0969 |
87-42-3 |
6-Chloropurine |
|
AS-0973 |
14548-39-1 |
6-Bromoindanone |
|
AS-0983 |
86639-52-3 |
7-Ethyl-10-hydroxycamptothecin |
|
AS-0985 |
16567-18-3 |
8-Bromoquinoline |
|
AS-1242 |
626-35-7 |
Ethyl nitroacetate |
|
AS-1257 |
1/4/5370 |
Mexiletine hydrochloride |
|
AS-1323 |
271-34-1 |
5-Azaindole |
|
AS-1325 |
392-13-2 |
5-Fluoro-3-methylindole |
|
AS-1330 |
3479-47-8 |
N-Cbz-L-Aspartic acid 4-benzyl ester |
|
AS-1331 |
3613-73-8 |
dimebolin |
|
AS-1337 |
1001-53-2 |
N-Acetylethylenediamine |
|
AS-1566 |
629-03-8 |
1,6-Dibromohexane |
|
AS-1567 |
2396-63-6 |
1,6-HEPTADIYNE |
|
AS-1569 |
98327-87-8 |
(+/-)-2,2'-Bis(diphenylphosphino)-1,1'-binaphthyl |
|
AS-1570 |
1780-19-4 |
1,2,3,4-Tetrahydroquinaldine |
|
AS-1814 |
143879-77-0 |
2,6-Difluoro-3-nitrobenzonitrile |
|
AS-2142 |
37777-76-7 |
2-Chloro-6-fluorophenylacetic acid |
|
AS-2327 |
18637-00-8 |
2-Ethoxybenzamidine hydrochloride |
|
AS-2685 |
7353-91-5 |
4-(N,N-DIMETHYL)ANILINEMAGNESIUM BROMIDE |
|
AS-4010 |
14907-27-8 |
D-Tryptophan methyl ester hydrochloride |
|
AS-4015 |
86123-10-6 |
Fmoc-D-phenylalanine |
|
AS-4017 |
101555-62-8 |
Fmoc-D-proline |
|
AS-4497 |
823-57-4 |
2-BROMO-5-CHLOROANILINE |
|
AS-6140 |
191226-98-9 |
tert-Butyl [(1S,2R)-1-benzyl-2-hydroxy-3-[isobutyl[(4-nitrophenyl)sulfonyl]amino]propyl]carbamate |
|
AS-6233 |
156311-83-0 |
(3-Hydroxy-3H-1,2,3-triazolo[4,5-b]pyridinato-O)tri-1-pyrrolidinylphosphonium hexafluorophosphate |
|
AS-6970 |
193269-78-2 |
1-Boc-3-(Amino)azetidine |
|
AS-7335 |
6287-38-3 |
3,4-Dichlorobenzaldehyde |
|
AS-7347 |
1/7/5840 |
Lilolidine |
|
AS-7499 |
4994-86-9 |
4-CHLORO-2-METHYLPYRIMIDINE |
|
AS-7771 |
65550-79-0 |
2-Bromo-5-chloronicotinic acid |
|
AS-7773 |
40635-67-4 |
2-Acetoxy-2-methylpropionyl bromide |
|
AS-7788 |
53348-05-3 |
3,6-Dibromo-phenanthrenequinone |
|
AS-8276 |
700874-72-2 |
LY 2157299 |
|
AS-8656 |
786616-54-4 |
Benzoic acid, 3-amino-5-fluoro- (9CI) |
|
|
|
|
|
|
|
|
|
|
|
|
|